home / stock / incr.u:cc / incr.u:cc news


INCR.U:CC News and Press, Intercure Ltd. Ordinary Shares From 11/15/22

Stock Information

Company Name: Intercure Ltd. Ordinary Shares
Stock Symbol: INCR.U:CC
Market: TSXC
Website: intercure.co

Menu

INCR.U:CC INCR.U:CC Quote INCR.U:CC Short INCR.U:CC News INCR.U:CC Articles INCR.U:CC Message Board
Get INCR.U:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

INCR.U:CC - InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth

Eleventh consecutive quarter of sequential profitable revenue growth Annualized revenue run rate of $1 55 million Adjusted EBITDA 1 run rate of $36 million Achieved Run Rate Net Profit of 12 $ million Strong...

INCR.U:CC - InterCure Announces Record Preliminary Third Quarter Revenue of Over CAD$39 million - 63% Growth YoY

Estimated revenue reaches CAD$39 million 1 (a record of over NIS 100 million) : Eleventh consecutive quarter of profitable growth with revenue growth expected to continue in Q4 2022 NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 11, 2022 (GLO...

INCR.U:CC - Intercure Ltd. Announces Voting Results from its Annual and Special Meeting of Shareholders

HERZLIYA, Israel, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Intercure Ltd. (the “Company”) announces today the results of the Annual and Special General Meeting of shareholders of the Company, held on Thursday, September 15, 2022, in Bnei Brak, Israel (the “Meeting”). A...

INCR.U:CC - InterCure Reports Record Breaking Second Quarter Financial Results

Record revenue of over $3 7 million i in the second quarter of 2022 Representing an annual run rate of $1 50 million Adjusted EBITDA ii for Q2 increased 90 % YoY to $ 9 millio...

INCR.U:CC - InterCure to Release its Q2 2022 Results and Hold a Conference Call

NEW YORK and TORONTO and HERZLIYA, Israel, Aug. 11, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that it plans to release financial results for the second quarter of 2022 afte...

INCR.U:CC - InterCure Reports Record Preliminary 2022 Second Quarter Revenue - More Than Double YoY and 9% QoQ Growth

Estimated r evenue reach es CAD$3 6 million 1 ( a record NIS 95 million ) Anticipates c ontinued increase s in EBITDA Revenue growth e xpected to continue in Q 3 and throughout 20...

INCR.U:CC - Clever Leaves Announces First Export to Israeli Partner InterCure

BOCA RATON, Fla., July 18, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today the first commer...

INCR.U:CC - InterCure and Cookies Launch Flagship Retail Location in Vienna, Austria

NEW YORK and TORONTO and HERZLIYA, Israel, June 21, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure" or the “Company”) announced today the successful opening of the first flagship Cookies store in Austria, located in the N...

INCR.U:CC - InterCure and Cookies Successfully Launch Flagship Pharmacy in Be'er Sheva, Israel

NEW YORK and TORONTO and HERZLIYA, Israel, June 02, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure" or the “Company”) announced today the grand opening of its flagship Cookies pharmacy in Be'er Sheva, the largest city in ...

INCR.U:CC - InterCure Begins 2022 with Record Breaking First Quarter Financial Results

Record revenue of $3 4 1 million in the first quarter of 2022 Adjusted EBITDA 2 increased almost 1 1 0% year-over-year to $8 million Net income of $ 6 million for the Q1 of 2022 compare d to ...

Previous 10 Next 10